Haleon (LSE:HLN) Accounts Payable : £3,599 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Accounts Payable?

Haleon's Accounts Payable for the quarter that ended in Jun. 2024 was £3,599 Mil.

Haleon's quarterly Accounts Payable declined from Dec. 2023 (£1,855 Mil) to Mar. 2024 (£0 Mil) but then increased from Mar. 2024 (£0 Mil) to Jun. 2024 (£3,599 Mil).

Haleon's annual Accounts Payable increased from Dec. 2021 (£1,369 Mil) to Dec. 2022 (£1,835 Mil) and increased from Dec. 2022 (£1,835 Mil) to Dec. 2023 (£1,855 Mil).

Haleon Accounts Payable Historical Data

The historical data trend for Haleon's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Accounts Payable Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

1,201.00

1,340.00

1,369.00

1,835.00

1,855.00

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable	Get a 7-Day Free Trial											-	1,855.00	-	3,599.00	-

Haleon Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Haleon Accounts Payable Related Terms

Thank you for viewing the detailed overview of Haleon's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (LSE:HLN) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN:USA HLNl:UK H6D0:Germany

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.